When drug discovery fails: scientists share their frustrations with the process

Physician Michael Hayden (right) is frustrated by the slow pace of drug development. Credit: Christopher Morris/Redux Pictures for Nature For scientists who are involved in drug discovery, failure is part of the job. Less than 15% of drug candidates make it to market from the laboratory. Most drugs don’t get through clinical trials because they aren’t effective enough or have unmanageable side effects. …